The bottom line Basal insulin and GLP-1 combinations like Xultophy and Soliqua can be a great option for managing type 2 diabetes
However, gathering these records and ensuring their legality can be a daunting task without proper legal guidance
In February 2025 , the FDA declared the semaglutide shortage resolved and began restricting compounding ( [62] )
Common side effects predominantly affect the gastrointestinal system and include: Nausea and vomiting (very common, especially during dose escalation) Diarrhoea or constipation Abdominal pain or discomfort Reduced appetite (intended therapeutic effect) Fatigue and dizziness These effects typically diminish as the body adjusts to the medication
How to Get 100% Clear, Glowing Skin: Complete Protocol IV drips are powerful, but they work best as part of a comprehensive skincare strategy
Post-Treatment Follow-Up At evaluation 3 months postradiation, the patients skin showed no residual reaction other than mild hyperpigmentation